Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 04/30/16
Due: 04/30/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Regimen for the Treatment of Cachexia in Subjects With NSCLC | NCT00527319 | Vicus Therapeutics | user2@example.com | None | 2007-01-31 | 2008-09-30 | 2009-09-30 | - | - | 2025-07-14 |
| Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer | NCT01857817 | Vicus Therapeutics | user2@example.com | None | 2013-06-30 | 2016-04-30 | 2017-04-30 | - | - | 2025-07-14 |
| Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) | NCT01265576 | Vicus Therapeutics | user2@example.com | None | 2010-12-31 | 2016-04-30 | 2017-04-30 | - | - | 2025-07-14 |